Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity

5 days ago 26

Novo Nordisk A/S (NYSE:NVO) is seeking FDA support for the pill mentation of its obesity drug, Wegovy. The institution precocious highlighted aboriginal information that shows information and efficacy figures that are akin to its injectables.
What Happened: On Wednesday, during Novo’s archetypal 4th earnings…

This communicative appeared connected benzinga.com, 2025-05-08 05:31:09.

Read Entire Article

Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity

Related

ESPN's new streaming app could replace cable for some but ma...

South Korea to help small, medium-sized firms hit by tariffs...

Rapper Tory Lanez is hospitalized after being stabbed in a C...

Trending

Popular

Toyota forecasts 35% fall in full-year net profit amid Trump...

Measles cases in Texas rise nearly 1% in three days, state h...

Earnings Beat: BeiGene, Ltd. Just Beat Analyst Forecasts, An...

Uber Stock Could Rise as High as $126, Says Wells Fargo

Deborah Seyram Adablah jabs judge as court issues warrant fo...